HealthTalk Live, Inc. (OTCPK:HLTK) entered into an agreement and plan of merger to acquire Humbly Hemp, Inc. from a group of investors in stock on October 1, 2016. HealthTalk will issue 12 million shares and will issue 5 million Series A Preferred Stock for 10 million Series A Preferred Stock of Daniel Crawford. The Preferred Stock is convertible to common stock at a rate of five shares for every share. HealthTalk will assume convertible promissory notes issued by Humbly Hemp. HealthTalk Live will assume: 12 Month 8% Convertible Promissory Note with principal amount of $0.01 million at conversion price of $0.01, 12 Month 8% Convertible Promissory Note with principal amount of $0.008 million at conversion price of $0.02, 12 Month 8% Convertible Promissory Note with principal amount of $0.005 million at conversion price of $0.01, 6 Month 6% Convertible Promissory Note with principal amount of $0.025 million at conversion price of $0.01 and 6 Month 6% Convertible Promissory Note with principal amount of $0.02 million at conversion price of $0.01. The investor group comprises of Jerry Grisaffi, Juan Martinez, Michael R. Welch, Theresa Powers, CrackerJack Classic LLC, David M. Seeberger, La Dolce Vida Trust, GCEF Opportunity Fund, LLC, Becca Ray, Alexis Grisaffi, Charles W. Smith, Daniel Crawford and William Kleidon. Post-closing, Humbly Hemp will become wholly-owned subsidiary of HealthTalk Live, Inc. Daniel Crawford – President, Chief Executive Officer, Chief Financial Officer and sole Director will remain as Officer and Director of Humbly Hemp, Inc. The transaction is subject to approval from shareholders of HealthTalk Live, Inc. and resignations of all Directors and Officers of HealthTalk Live, Inc. The transaction was unanimously approved by Board of Directors of Humbly Hemp, Inc. and HealthTalk Live, Inc. Joe Laxague of Laxague Law, Inc. acted as the legal advisor for Humbly Hemp, Inc.